Humoral Responses after SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients-Reference-Cited by-同舟云学术

Humoral Responses after SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients

Published:2021-12 Issue: Volume: Page:
ISSN:2542-4548
Container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
language:en
Short-container-title:Mayo Clinic Proceedings: Innovations, Quality & Outcomes

Author:

Chumsri Saranya^ORCID,Advani Pooja P.,Pai Tanmayi S.,Li Zhuo,Mummareddy Ashita^ORCID,Acampora Marites,Reynolds Gina A.,Wylie Natasha,Boyle Ashton W.,Lou Yanyan,Mody Kabir,Moreno-Aspitia Alvaro^ORCID,Swift Melanie D.,Virk Abinash,Bharucha Adil E.,Marquez Christopher P.,Patel Tushar C.,Gores Gregory J.,Knutson Keith L.

Funder

Mayo Clinic

Publisher

Elsevier BV

Subject

General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis;Human Vaccines & Immunotherapeutics;2024-05-24

2. Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study;Frontiers in Oncology;2023-11-07

3. COVID-19 mRNA Vaccination Trends Among Immunocompromised Patients;The Journal of the American Board of Family Medicine;2023-11

4. Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis;Cancers;2023-04-12

5. Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemia;Leukemia & Lymphoma;2023-03-12